Back to search

Article

Omicron-specific mRNA vaccine elicits potent immune responses in mice, hamsters, and nonhuman primates

2022-03-01

Abstract excerpt

<h4>ABSTRACT</h4> SARS-CoV-2 has infected more than 400 million people around the globe and caused millions of deaths. Since its identification in November 2021, Omicron, a highly transmissible variant, has become the dominant variant in most countries. Omicron’s highly mutated spike protein, the main target of vaccine development, significantly compromises the immune protection from current vaccination. We devel...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1d74c75a-bc01-5353-9df6-16349b86e1d6
DOI
10.1101/2022.03.01.481391
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Omicron-specific mRNA vaccine elicits potent immune responses in mice, hamsters, and nonhuman primatesDOI 10.1101/2022.03.01.481391
Select a neighboring publication to make it the new centre.